Scholar Rock Holding buy Jefferies Financial Group Inc.
Start price
21.08.25
/
50%
€30.60
Target price
21.08.26
€42.92
Performance (%)
29.41%
Price
10:44
€39.60
Summary
This prediction is currently active. The BUY prediction by Jefferies_Financial_ currently has a performance of 29.41%. This prediction currently runs until 21.08.26. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionScholar Rock is a clinical-stage biopharmaceutical company that engages in the discovery and development of innovative medicines to treat serious diseases in patients that currently have limited or no treatment options. Their pipeline consists of a number of product candidates that target growth factor signaling pathways within the human body. These products hold potential for the treatment of multiple diseases, including neuromuscular disorders, cancer, and fibrosis. Scholar Rock, which trades under the symbol SRRK, is listed on the NASDAQ stock exchange.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Scholar Rock Holding | 3.093% | 3.093% |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by Jefferies_Financial_ for this prediction
In the thread Scholar Rock Holding diskutieren
Scholar Rock (NASDAQ:SRRK) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $50.00 price target on the stock.
Ratings data for SRRK provided by MarketBeat
Stopped prediction by Jefferies_Financial_ for Scholar Rock Holding
Scholar Rock Holding
Start price
Target price
Perf. (%)
€8.55
25.10.23
25.10.23
€18.91
25.10.24
25.10.24
220.47%
26.10.24
26.10.24
